Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants

Antiviral Research

Volumn 88, Issue 2, 2010, Pages 152-159

  de Arellano, Eva Ramírez ^a,b   Alcamí, José ^b   López, Marisa ^a   Soriano, Vincent ^a   Holguín, África ^c  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

HIV 1; Hypermutation; LTR; Non B subtypes; Transcription

Indexed keywords

LUCIFERASE; PROTEINASE; TRANSACTIVATOR PROTEIN;

ARTICLE; CLADISTICS; GENE ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; VIRUS STRAIN; WILD TYPE;

ADULT; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; GENES, TAT; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV PROTEASE; HIV-1; HUMANS; LUCIFERASES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NF-KAPPA B; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; SP1 TRANSCRIPTION FACTOR; SPAIN; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77958150806     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.08.007     Document Type: Article

References (35)

1. Alcamí J., Laín de Lera T., Folgueira L., Pedraza M.A., Jacque J.M., Bachelerie F., Noriega A.R., Hay R.T., Harrich D., Gaynor R.B. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 1995, 14:1552-1560.
2. Centlivre M., Sommer P., Michel M., Ho Tsong Fang R., Gofflo S., Valladeau J., Schmitt N., Thierry F., Hurtrel B., Wain-Hobson S., Sala M. HIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo. J. Clin. Invest. 2005, 115:348-358.
3. Centlivre M., Sommer P., Michel M., Ho Tsong F.R., Gofflo S., Valladeau J., Schmitt N., Wain-Hobson S., Sala M. The HIV-1 clade C promoter is particularly well adapted to replication in the gut in primary infection. AIDS 2006, 20:657-666.
4. Chen F.E., Huang D.B., Chen Y.Q., Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappa bound to DNA. Nature 1998, 391:410-413.
5. De Baar M.P., De Ronde A., Berkhout B., Cornelissen M., Van der Horn K.H., Van der Schoot A.M., De Wolf F., Lukashov V.V., Goudsmit J. Subtype-specific sequence variation of the HIV-1 type 1 long terminal repeat and primer-binding site. AIDS Res. Hum. Retroviruses 2000, 16:499-504.
6. Desfosses Y., Solis M., Sun Q., Grandvaux N., Van Lint C., Burny A., Gatignol A., Wainberg M.A., Lin R., Hiscott J. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins. J. Virol. 2005, 79:9180-9191.
7. El Kharroubi A., Martin M.A. Cis-acting sequences located downstream of the HIV type 1 promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 1996, 16:2958-2966.
8. Estable M.C., Bell B., Hirst M., Sadowski I. Naturally occurring HIV-1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription. J. Virol. 1998, 72:6465-6474.
9. Fourati S., Malet I., Binka M., Boukobza S., Soulié C., Simon A., Katlama C., Simon V., Calvez V., Marcelin A.-G. A new mechanism enhancing the ability of HIV to escape from antiretrovirals. 17th Conference on Retroviruses and Opportunistic Infections 2010, Abstracts, no. 90.
10. Hazan U., Thomas D., Alcami J., Bachelerie F., Israel N., Yssel H., Virelizier J.L., Arenzana-Seisdedos F. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-kappa B translocation but not human immunodeficiency virus 1 enhancer-dependent transcription. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:7861-7865.
11. Holguín A., Alvarez A., Soriano V. Heterogeneous nature of HIV-1 recombinants spreading in Spain. J. Med. Virol. 2005, 75:374-380.
12. Holguín A., Alvarez A., Soriano V. Differences in the length of gag proteins among different HIV type 1 subtypes. AIDS Res. Hum. Retroviruses 2005, 21:886-893.
13. Jeeninga R.E., Hoogenkamp M., Armand-Ugon M., de Baar M., Verhoef K., Berkhout B. Functional differences between the long terminal repeat transcriptional promoters of HIV type 1 subtypes A through G. J. Virol. 2000, 74:3740-3751.
14. Jin X., Brooks A., Chen H., Bennett R., Reichman R., Smith H. APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia. J. Virol. 2005, 79:11513-11516.
15. Jones K.A., Kadonaga J.T., Luciw P.A., Tjian R. Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 1986, 232:755-759.
16. Kantor R., Katzenstein D. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution. AIDS Rev. 2003, 5:25-35.
17. Kieffer T.L., Kwon P., Nettles R.E., Han Y., Ray S.C., Siliciano R.F. G-A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J. Virol. 2005, 79:1975-1980.
18. Krebs F.C., Hogan T.H., Quiterio S., Gartner S., Wigdahl B. Lentiviral LTR-directed Expression, Sequence Variation, and Disease Pathogenesis. HIV Sequence Compendium, 29-70. 2001, Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, LA-UR 02-2877. C. Kuiken, B. Foley, B. Hahn, P. Marx, F. McCutchan, J.W. Mellors, S. Wolinsky, B. Korber (Eds.).
19. Kurosu T., Mukai T., Komoto S., Ibrahim M.S., Li Y.G., Kobayashi T., Tsuji S., Ikuta K. Human immunodeficiency virus type 1 subtype C exhibits higher transactivation activity of Tat than subtypes B and E. Microbiol. Immunol. 2002, 46:787-799.
20. Lisovsky I., Schader S.M., Oliveira M., Wainberg M.A. HIV-1 inter-subtype vif variability affects APOBEC-3G mediated host restriction. 17th Conference on Retroviruses and Opportunistic Infections 2010, Abstracts, no. 206.
21. Lospitao E., Alvarez A., Soriano V., Holguín A. HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003. HIV Med. 2005, 6:313-320.
22. Montano M.A., Novitsky V.A., Blackard J.T., Cho N.L., Katzenstein D.A., Essex M. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J. Virol. 1997, 71:8657-8665.
23. Montano M.A., Nixon C.P., Essex M.I. Dysregulation through the NF-kappaB enhancer and TATA box of the HIV type 1 subtype E promoter. J. Virol. 1998, 72:8446-8452.
24. Naghavi M.H., Schwartz S., Sönnerborg A., Vahlne A. Long terminal repeat promoter/enhancer activity of different subtypes of HIV-1. AIDS Res. Hum. Retroviruses 1999, 15:1293-1303.
25. Pereira L.A., Bentley K., Peeters A., Churchill M.J., Deacon N.J. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 2000, 28:663-668.
26. Perkins N.D., Edwards N.L., Duckett C.S., Agranoff A.B., Schmid R.M., Nabel G.J. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J. 1993, 12:3551-3558.
27. Ramírez de Arellano E., Soriano V., Holguín A. Genetic analysis of regulatory, promoter, and TAR regions of LTR sequences belonging to HIV-1 non-B subtypes. AIDS Res. Hum. Retroviruses 2005, 21:949-954.
28. Rodríguez M.A., Shen C., Ratner D., Paranjape R.S., Kulkarni S.S., Chatterjee R., Gupta P. Genetic and functional characterization of the LTR of HIV-1 subtypes A and C circulating in India. AIDS Res. Hum. Retroviruses 2007, 23:1428-1433.
29. Roof P., Ricci M., Genin P., Montano M.A., Essex M., Wainberg M.A., Gatignol A., Hiscott J. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator. Virology 2002, 296:77-83.
30. Schwartz O., Virelizier J.L., Montagnier L., Hazan U. A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene 1990, 88:197-205.
31. Van Lint C., Amella C.A., Emiliani S., John M., Jie T., Verdin E. Transcription factor binding sites downstream of the HIV type 1 transcription start site are important for virus infectivity. J. Virol. 1997, 71:6113-6127.
32. Van Opijnen T., Jeeninga R.E., Boerlijst M.C., Pollakis G.P., Zetterberg V., Salminen M., Berkhout B. Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J. Virol. 2004, 78:3675-3683.
33. Yebra G., de Mulder M., del Romero J., Rodríguez C., Holguín A. HIV-1 non-B subtypes: high transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability. Antiviral Res. 2010, 85:409-417.
34. Yukl S., Pillai S., Li P., Chang K., Pasutti W., Ahlgren C., Havlir D., Strain M., Günthard H., Richman D., Rice A.P., Daar E., Little S., Wong J.K. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology 2009, 25:98-108.
35. Zhang L., Huang Y., Yuan H., Chen B.K., Ip J., Ho D.D. Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 1997, 71:5608-5613.